Latest Breaking News On - Ferenc tracik - Page 3 : comparemela.com

NeuroSense Therapeutics to Participate in BIO-Europe Spring

/PRNewswire/ NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today.

United kingdomFerenc tracikPrnewswire neurosense therapeutics ltdBusiness development nedira salzman frenkelNeurosense therapeutics ltdSense therapeuticsChief medical officerEurope spring

Neurosense Therapeutics (NRSN) Receives Approval in Germany to Enroll Patients in its Phase 2b ALS Trial

Neurosense Therapeutics (NRSN) Receives Approval in Germany to Enroll Patients in its Phase 2b ALS Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ferenc tracikGermany federal institute for drugsCompany clinical trial applicationNeurosense therapeutics ltdWall streetSense therapeuticsFederal instituteMedical devicesClinical trial applicationChief medical officer

NeuroSense Receives Approval in Germany to Enroll Patients in its Phase 2b ALS Trial

/PRNewswire/ NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today.

United statesUnited kingdomFerenc tracikGermany federal institute for drugsPrnewswire neurosense therapeutics ltdDrug administrationNeurosense therapeutics ltdCompany clinical trial applicationEuropean medicines agencySense therapeuticsFederal instituteMedical devicesClinical trial applicationChief medical officerMassachusetts general hospitalNeuron derived exosomes

NeuroSense Announces Third Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today.

United kingdomLoma linda universityUnited statesSan franciscoNiva russekJeremy shefnerJeffrey rosenfeldCharles duncanFerenc tracikShiran zimriNedira salzman frenkelAmyotrophic lateral sclerosis consortiumNeurosense head of the scientific programCompany investigational new drugPrnewswire neurosense therapeutics ltdDrug administration

NeuroSense Therapeutics to Present at Upcoming Leading Neuroscience Conferences

/PRNewswire/ NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today.

United statesSan diegoUnited kingdomClearwater beachNiva russek blumShiran zimriFerenc tracikAmyotrophic lateral sclerosis consortiumNeurosense head of scientific programResearch ambassadorsInternational symposiumPrnewswire neurosense therapeutics ltdNeurosense therapeutics ltdHot topicSociety for neuroscience sfnNeals peace committee